GlassScriptPhysician profile
David L Kaufmann
NPI 1144204223
$4,256.63
in general payments reported to CMS, 2019-2025
9 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $334 · 2021: $134 · 2022: $218 · 2023: $1,713 · 2024: $751 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396 · Travel and Lodging: $852 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,396.20 |
| Travel and Lodging | $851.89 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,889.23 | 2019-2025 | Proclaim, Penta |
| Medtronic, INC. | $1,423.16 | 2021-2025 | Cd Horizon Spinal System, Intellis Adaptivestim, Inceptiv |
| Cerapedics INC. | $522.42 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $134.37 | 2022 | |
| Kuros Biosciences USA, INC | $97.87 | 2025 | Magnetos |
| Depuy Synthes Sales INC. | $89.21 | 2024 | Teligen |
| Stryker Corporation | $42.92 | 2023 | Universal Neuro 3 |
| Boston Scientific Corporation | $37.45 | 2025 | General - Pain Management |
| Csl Behring | $20.00 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaufmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.